3 New Strong Buy Ratings from Top-Rated Analysts: 05/19/2026
Lucky you: Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:
- Electromed Inc (ELMD) — Record Q3 results fuel double-digit growth momentum.
- Garrett Motion Inc (GTX) — Unanimous Strong Buy coverage with 16% upside ahead.
- Aveanna Healthcare Holdings (AVAH) — Home healthcare leader eyes 42% upside potential.
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Elon Musk Deploys Next Big Project (Not Space or AI) Elon Musk is rolling out a breakthrough technology that could replace our need for foreign oil and ignite a $10 trillion boom a small group of stocks. Find Out More Here...1. Electromed (NYSEMKT: ELMD)
This innovative medical device maker — armed with its SmartVest airway clearance therapy system — is taking on the underserved bronchiectasis market with serious firepower. Record Q3 2026 results just delivered 18.4% revenue growth and strong operating leverage, positioning ELMD for sustained double-digit growth that has Wall Street paying close attention.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $35.68 — get current quote
Max 1-year forecast: $40.00
Why we're watching:
- Analyst support: While coverage is limited to 2 analysts, it is resoundingly bullish — both are Strong Buy ratings. See the ratings here
- B. Riley Securities researcher Kyle Bauser (a top 21% rated analyst) recently raised the price target to $40 following record Q3 2026 earnings. Bauser noted the quarter's "record" results were highlighted by 18.4% revenue growth and strong operating leverage, delivered by strength in homecare and a hospital rebound, and the company appears positioned for sustained double-digit growth supported by expanding adoption, payer coverage, and a large underpenetrated bronchiectasis market.
- The company delivered a 34.62% EPS beat in Q3 with actual earnings of $0.35 versus estimates of $0.26, while revenue grew 19.20% year-over-year to $18.58 million and beat expectations by 4.35%.
- Management highlighted that 86% of covered lives in the United States are now under contract and manufacturing optimization is complete, positioning the company to capture opportunities in the underserved bronchiectasis market.
- Industry ranking context: ELMD is currently the 2nd highest-rated stock in the Medical Device industry.
- Zen Rating highlights: ELMD is an A-rated stock in our Zen Ratings system, a tier that only includes the top 5% of the 4600+ stocks we track. All of these stocks have passed a rigorous 115-factor review with flying colors.
- Component Grades: The 115 factors we explore are divided into 7 Components, which are graded separately. The company excels with an A grade in Sentiment reflecting strong analyst optimism and an A grade in Financials backed by a healthy 16.2% profit margin and minimal debt-to-equity ratio of 0.21. See all 7 Zen Component Grades here
2. Garrett Motion (NASDAQ: GTX)
The global leader in turbocharger and electric-boosting technologies is making bold moves — a strategic partnership with Ingersoll Rand is ushering in a new era for oil-free industrial innovation, while strong Q1 results just prompted management to raise its 2026 outlook. GTX is firing on all cylinders, and analysts are taking notice.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $30.98 — get current quote
Max 1-year forecast: $36.00
Why we're watching:
- Analyst support: Among the 5 analysts we track issuing ratings on GTX, you’ll see 4 Strong Buy ratings and 1 Buy rating with 0 Hold or Sell ratings, reflecting strong Wall Street confidence. See the ratings
- For example, Stifel Nicolaus' Nathan Jones (a top 2% rated analyst) maintains a Strong Buy rating with the highest price target of $36, representing +16.20% upside potential.
- BWS Financial's Hamed Khorsand (a top 2% rated analyst) maintains a Buy rating with a $32 price target, showing consistent support from top-tier analysts.
- Industry ranking context: GTX is currently the 5th highest-rated stock in the Auto Part industry, which has an Industry Rating of B.
- Zen Rating highlights: With its A (Strong Buy) Ratings, GTX is in a class of stocks that have historically delivered 32.52% annual returns.
- Component Grades: The company demonstrates balanced strength with B grades in Momentum and Safety, which is bolstered and supported by solid operational cash flow of $455M and strong earnings growth forecasts. See all 7 Zen Component Grades here
3. Aveanna Healthcare Holdings (NASDAQ: AVAH)
This nationwide home healthcare powerhouse — covering private duty nursing, adult home health and hospice, pediatric therapy, and enteral nutrition services — is firing on all cylinders. AVAH just topped Q1 2026 earnings and revenue estimates, announced revised 2026 guidance, and scored a fresh Strong Buy upgrade from Stephens & Co. that's putting it squarely on Wall Street's radar.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $7.72 — get current quote
Max 1-year forecast: $11.00
Why we're watching:
- Analyst support: AVAH enjoys 2 Strong Buy, 1 Buy, and 3 Hold ratings among the analysts we track — an overall Buy consensus. See the ratings
- Stephens & Co. researcher Scott Fidel (a top 15% rated analyst) recently upgraded the stock to Strong Buy with a price target of $11, representing +42.49% upside potential.
- Even the Hold ratings suggest upside, though. RBC Capital's Ben Hendrix (a top 13% rated analyst) maintains a Hold rating but with a $10 price target that still implies +29.53% upside, suggesting potential for rating upgrades ahead.
- Industry ranking context: AVAH is currently the 3rd highest-rated stock in the Medical Care Facility industry, which has an Industry Rating of A, placing it in an attractive sector.
- Zen Rating highlights: AVAH earns an overall Zen Rating of A, putting it in the top tier of stocks we track based on a rigorous 115-factor review. Stocks in this category have historically delivered market-beating returns.
- Component Grades: Looking at the Component Grades that shape the overall rating, the stock shines with an A grade in Sentiment reflecting strong analyst optimism post-earnings and a B grade in Value, suggesting a potentially attractive entry point. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.